Page 2276 - Williams Hematology ( PDFDrive )

2250 Part XII: Hemostasis and Thrombosis Chapter 131: The Antiphospholipid Syndrome 2251

325. Wu XX, Guller S, Rand JH: Hydroxychloroquine reduces binding of antiphospholipid 335. Piantoni S, Andreoli L, Allegri F, et al: Low levels of vitamin D are common in primary
antibodies to syncytiotrophoblasts and restores annexin A5 expression. Am J Obstet antiphospholipid syndrome with thrombotic disease. Reumatismo 64:307–313, 2012.
Gynecol 205:576.e7–576.e14, 2011. 336. Erkan D, Aguiar CL, Andrade D, et al: 14th International Congress on Antiphospho-
326. Mok MY, Chan EY, Fong DY, et al: Antiphospholipid antibody profiles and their clin- lipid Antibodies: Task force report on antiphospholipid syndrome treatment trends.
ical associations in Chinese patients with systemic lupus erythematosus. J Rheumatol Autoimmun Rev 13:685–696, 2014.
32:622–628, 2005. 337. Kutteh WH: Antiphospholipid antibody-associated recurrent pregnancy loss: Treat-
327. Wahl DG, Bounameaux H, de MP, Sarasin FP: Prophylactic antithrombotic therapy ment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am
for patients with systemic lupus erythematosus with or without antiphospholipid J Obstet Gynecol 174:1584–1589, 1996.
antibodies: Do the benefits outweigh the risks? A decision analysis. Arch Intern Med 160: 338. Rai R, Cohen H, Dave M, Regan L: Randomised controlled trial of aspirin and aspirin
2042–2048, 2000. plus heparin in pregnant women with recurrent miscarriage associated with phospho-
328. Schmidt-Tanguy A, Voswinkel J, Henrion D, et al: Antithrombotic effects of hydroxy- lipid antibodies (or antiphospholipid antibodies) [see comments]. BMJ 314:253–257,
chloroquine in primary antiphospholipid syndrome patients. J Thromb Haemost 1997.
11:1927–1929, 2013. 339. Cohn DM, Goddijn M, Middeldorp S, et al: Recurrent miscarriage and antiphospho-
329. Bezati E, Wu XX, Quinn A, et al: A new trick for an ancient drug: Quinine dissociates lipid antibodies: Prognosis of subsequent pregnancy. J Thromb Haemost 8:2208–2213,
antiphospholipid immune complexes. Lupus 24:32–41, 2014. 2010.
330. Lopez-Pedrera C, Ruiz-Limon P, Aguirre MA, et al: Global effects of fluvastatin on 340. Bramham K, Thomas M, Nelson-Piercy C, et al: First trimester low-dose prednisolone
the prothrombotic status of patients with antiphopholipid syndrome. Ann Rheum Dis in refractory antiphospholipid antibody-related pregnancy loss. Blood 117:6948–6951,
70:675–682, 2011. 2011.
331. Erkan D, Willis R, Murthy VL, et al: A prospective open-label pilot study of fluvastatin 341. Dendrinos S, Sakkas E, Makrakis E: Low-molecular-weight heparin versus intravenous
on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody pos- immunoglobulin for recurrent abortion associated with antiphospholipid antibody
itive patients. Ann Rheum Dis 73:1176–1180, 2014. syndrome. Int J Gynaecol Obstet 104:223–225, 2009.
332. Erkan D, Vega J, Ramon G, et al: A pilot open-label phase II trial of rituximab for non- 342. Sherer Y, Levy Y, Shoenfeld Y: Intravenous immunoglobulin therapy of antiphospho-
criteria manifestations of antiphospholipid syndrome. Arthritis Rheum 65:464–471, lipid syndrome. Rheumatology 39:421–426, 2000.
2013. 343. Branch DW, Peaceman AM, Druzin M, et al: A multicenter, placebo-controlled pilot
333. Agmon-Levin N, Blank M, Zandman-Goddard G, et al: Vitamin D: An instrumental study of intravenous immune globulin treatment of antiphospholipid syndrome during
factor in the anti-phospholipid syndrome by inhibition of tissue factor expression. Ann pregnancy. The Pregnancy Loss Study Group. Am J Obstet Gynecol 182:122–127, 2000.
Rheum Dis 70:145–150, 2011.
334. Andreoli L, Piantoni S, Dall’Ara F, et al: Vitamin D and antiphospholipid syndrome.
Lupus 21:736–740, 2012.

Kaushansky_chapter 131_p2233-2252.indd 2251 9/18/15 5:11 PM